Combination of motesanib, a taxane and a platinum-containing anti-cancer drug for use in the treatment of non-small cell lung cancer in a population subset

• 收藏
• 分享

专利权人:

Amgen Inc.

发明人:

Hei, Yong-Jiang,Yao, Bin

申请号：

AU2012242773

公开号：

AU2012242773A1

申请日:

2012.04.12

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The present invention provides a method of improving survival associated with cancer in a subset of the general population. The invention provides a method of improving survival associated with cancer in patients of Asian ethnic background. In addition, the present application relates to the treatment of angiogenesis related disease in an Asian patient with kinase inhibitors. In addition the present application relates to the treatment of non-small cell lung cancer in an Asian patient with motesanib.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/